Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SANA

Sana Biotechnology (SANA)

Sana Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SANA
DateTimeSourceHeadlineSymbolCompany
03/03/20234:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
03/03/20234:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
03/03/20234:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
03/03/20234:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
03/01/20234:05PMGlobeNewswire Inc.Sana Biotechnology to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:SANASana Biotechnology Inc
02/09/20238:16AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SANASana Biotechnology Inc
02/02/20234:05PMGlobeNewswire Inc.Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology ConferenceNASDAQ:SANASana Biotechnology Inc
01/26/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SANASana Biotechnology Inc
01/26/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SANASana Biotechnology Inc
01/26/20234:05PMGlobeNewswire Inc.Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell MalignanciesNASDAQ:SANASana Biotechnology Inc
01/20/20237:42AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SANASana Biotechnology Inc
01/03/20234:05PMGlobeNewswire Inc.Sana Biotechnology to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SANASana Biotechnology Inc
12/11/20225:30PMGlobeNewswire Inc.Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual MeetingNASDAQ:SANASana Biotechnology Inc
11/29/20224:05PMGlobeNewswire Inc.Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio PrioritizationNASDAQ:SANASana Biotechnology Inc
11/14/20224:05PMGlobeNewswire Inc.Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking in Small Employer CategoryNASDAQ:SANASana Biotechnology Inc
11/03/20229:07AMGlobeNewswire Inc.Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual MeetingNASDAQ:SANASana Biotechnology Inc
11/02/20224:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SANASana Biotechnology Inc
11/02/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SANASana Biotechnology Inc
11/02/20224:05PMGlobeNewswire Inc.Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
11/01/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SANASana Biotechnology Inc
10/06/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
09/16/20226:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
09/16/20226:52PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SANASana Biotechnology Inc
09/09/20224:05PMGlobeNewswire Inc.Sana Biotechnology to Present at September 2022 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
08/04/20225:28PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:SANASana Biotechnology Inc
08/04/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SANASana Biotechnology Inc
08/04/20224:05PMGlobeNewswire Inc.Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
07/07/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
06/17/20229:00AMGlobeNewswire Inc.Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting Showing Survival of Transplanted Hypoimmune iPSC-Derived Differentiated Cell Types Without Immunosuppression in Non-Human PrimatesNASDAQ:SANASana Biotechnology Inc
06/15/20226:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:SANA